{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:08:44Z","timestamp":1791079724091,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ejphar.2008.07.022","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T08:42:34Z","timestamp":1216370554000},"page":"101-108","source":"Crossref","is-referenced-by-count":49,"title":["Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats"],"prefix":"10.1016","volume":"594","author":[{"given":"Caroline","family":"Capitelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Sereniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Meira Santos","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Braga","family":"Reksidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Barbato Fraz\u00e3o","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.07.022_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molstruc.2006.12.018","article-title":"Melatonin affects the order, dynamics and hydration of brain membrane lipids","volume":"384\u2013386","author":"Akkas","year":"2007","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejphar.2008.07.022_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2008.07.022_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0197-0186(94)00154-M","article-title":"Melatonin stimulates brain glutathione peroxidase activity","volume":"26","author":"Barlow-Walden","year":"1995","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2008.07.022_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(02)00144-1","article-title":"Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats","volume":"323","author":"Baydas","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2008.07.022_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-079X.2005.00212.x","article-title":"Learning and memory deficits in rats induced by chronic thinner exposure are reversed by melatonin","volume":"39","author":"Baydas","year":"2005","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1087-0792(98)90020-X","article-title":"Basic aspects of melatonin action","volume":"2","author":"Cardinali","year":"1998","journal-title":"Sleep M\u00e9d. Rev."},{"key":"10.1016\/j.ejphar.2008.07.022_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002210050619","article-title":"The antioxidant melatonin prevents kainate-induced neuronal degenerating death in the rat striatum","volume":"124","author":"Chen","year":"1999","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1034\/j.1600-079X.2002.01871.x","article-title":"Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway","volume":"32","author":"Chen","year":"2002","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib11","doi-asserted-by":"crossref","first-page":"589-597","DOI":"10.1016\/j.nut.2007.05.004","article-title":"Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice","volume":"23","author":"Chen","year":"2007","journal-title":"Nutrition"},{"key":"10.1016\/j.ejphar.2008.07.022_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2004.08.068","article-title":"The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells","volume":"371","author":"Chetsawang","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2008.07.022_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0006-8993(97)00188-1","article-title":"Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats","volume":"755","author":"Cho","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","article-title":"The basic physiology and pathophysiology of melatonin","volume":"9","author":"Claustrat","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.ejphar.2008.07.022_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.pnpbp.2004.05.023","article-title":"Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants","volume":"28","author":"Cui","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.07.022_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanism and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2008.07.022_bib19","first-page":"781","article-title":"The absolute bioavailability of oral melatonin","volume":"40","author":"DeMuro","year":"2000","journal-title":"Altern. Herbal Med."},{"key":"10.1016\/j.ejphar.2008.07.022_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2006.06.024","article-title":"Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition (review)","volume":"545","author":"Di Filippo","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tox.2006.05.011","article-title":"Comparative study of natural antioxidants\u2014 curcumin, resveratrol and melatonin \u2014 in cadmium-induced oxidative damage in mice","volume":"225","author":"Eybl","year":"2006","journal-title":"Toxicol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02260967","article-title":"MPTP-induced behavioural and biochemical deficits: a parametric analysis","volume":"7","author":"Fredriksson","year":"1994","journal-title":"J. Neural Transm., Parkinson's Dis. Dement. Sect."},{"key":"10.1016\/j.ejphar.2008.07.022_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0165-6147(03)00176-7","article-title":"Novel anti-inflammatory therapy for Parkinson's disease","volume":"24","author":"Gao","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.07.022_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00230443","article-title":"Serotonergic sprouting in primate MPTP-induced hemiparkinsonism","volume":"96","author":"Gaspar","year":"1993","journal-title":"Exp. Brain Res.,"},{"key":"10.1016\/j.ejphar.2008.07.022_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","article-title":"The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.","volume":"5","author":"German","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejphar.2008.07.022_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1461145701002619","article-title":"L-DOPA restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats","volume":"4","author":"Gevaerd","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biocel.2005.08.020","article-title":"Melatonin","volume":"38","author":"Hardeland","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib28","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2008.07.022_bib29","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-treated mouse as a model of parkinsonism: how good is it?","author":"Heikkila","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2008.07.022_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(98)00170-0","article-title":"Melatonin protects nigral dopaminergic neurons from 1-metyl-4-phenylpyridinium (MPP+) neurotoxicity in rats","volume":"245","author":"Jin","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2008.07.022_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.106.119206","article-title":"Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum","volume":"322","author":"Kawasaki","year":"2007","journal-title":"J. Pharmacol. Exp. Ther.,"},{"key":"10.1016\/j.ejphar.2008.07.022_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0197-4580(02)00133-1","article-title":"Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion","volume":"24","author":"Khaldy","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2008.07.022_bib33","first-page":"502","article-title":"Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management","volume":"5","author":"Kidd","year":"2000","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.ejphar.2008.07.022_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00441-004-0975-6","article-title":"Parkinson's disease: clinical aspects","volume":"318","author":"Klockgether","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ejphar.2008.07.022_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produced time-dependent induction COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib36","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S1389-9457(07)70389-1","article-title":"The role of the dopaminergic pathway in regulating sleep\u2013wake patterns in a model of Parkinson's Disease in rats","volume":"8","author":"Lima","year":"2007","journal-title":"Sleep Med."},{"key":"10.1016\/j.ejphar.2008.07.022_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-079X.1998.tb00531.x","article-title":"Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: Implications for Parkinson's disease","volume":"24","author":"Mayo","year":"1998","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","article-title":"Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions","volume":"58","author":"Miyoshi","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2008.07.022_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2005.03.053","article-title":"Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rats striatum.","volume":"1046","author":"Nam","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2004.03.072","article-title":"Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease","volume":"363","author":"Park","year":"2004","journal-title":"Neurosci. Lett.,"},{"key":"10.1016\/j.ejphar.2008.07.022_bib42","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2008.07.022_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2008.07.022_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2003.11.029","article-title":"Behavioural and neurochemical effects phosphatidylserine in MPTP lesion of the substantia nigra of rats","volume":"484","author":"Perry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2005.05.009","article-title":"Intra-nigral MPTP lesion in rats: behavioural and autoradiography studies","volume":"195","author":"Perry","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib47","first-page":"359","article-title":"Oxidative damage in the central nervous system: protection by melatonin","volume":"56","author":"Reiter","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jneumeth.2007.08.024","article-title":"Repeated intranigral MPTP administration: A new protocol of prolonged locomotor impairment mimicking Parkinson's disease","volume":"167","author":"Reksidler","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2008.07.022_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: a significant role for melatonin","volume":"36","author":"Rodriguez","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib51","first-page":"197","article-title":"A marker of oxyradical-mediated DNA damage (8-hydroxy-2'-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain","volume":"3","author":"Sanchez-Ramos","year":"1994","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejphar.2008.07.022_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/1055-8330(95)90014-4","article-title":"Cognitive deficits precede motor deficits in a slowly progressing model of Parkinsonism in the monkey","volume":"4","author":"Schneider","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejphar.2008.07.022_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00441-004-0954-y","article-title":"Neuronal pathology in Parkinson's disease","volume":"318","author":"Schulz","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ejphar.2008.07.022_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3940(95)11803-5","article-title":"H2O2-induced lipid peroxidation in rat brain homogenates is greatly reduced by melatonin","volume":"195","author":"Sewerynek","year":"1995","journal-title":"Neurosc. Lett."},{"key":"10.1016\/j.ejphar.2008.07.022_bib57","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1002\/ana.410320720","article-title":"Mitochondrial function in Parkinson's disease","volume":"32","author":"Shapira","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiology neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R","article-title":"Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease","volume":"46","author":"Shimura-Miura","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ygcen.2006.02.009","article-title":"Mice convert melatonin to 6-sulphatoxymelatonin","volume":"147","author":"Skene","year":"2006","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pbb.2006.09.009","article-title":"Melatonin administration impairs visuo-spatial performance and inhibits neocortical long-term potentiation in rats","volume":"85","author":"Soto-Moyano","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2008.07.022_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(02)02269-2","article-title":"Antioxidant compounds protect dopamine neurons from death due to oxidative stress in vitro","volume":"931","author":"Stull","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2007.06.011","article-title":"Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats","volume":"571","author":"Subramanian","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib64","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.parkreldis.2005.02.011","article-title":"Controversy: is Parkinson's disease entity? Yes","volume":"11","author":"Takahashi","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ejphar.2008.07.022_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-079X.2006.00407.x","article-title":"One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?","volume":"42","author":"Tan","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2008.07.022_bib66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2008.07.022_bib67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neures.2003.10.012","article-title":"SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"48","author":"Wang","year":"2004","journal-title":"Neurosc. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908007620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908007620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T05:57:02Z","timestamp":1545890222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908007620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":62,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0014299908007620"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.07.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}